Patents by Inventor Alexander Lowe

Alexander Lowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109563
    Abstract: An enclosure system attachable to a railway vehicle to protect automobiles in the event of a collision. The enclosure system having an enclosure panel that is actuatable between a deployed configuration and a stowed configuration. A breakaway mechanism configured to allow certain components of enclosure system to release from the railway vehicle in the event of a collision with another railway vehicle to ensure the anticlimbers engage between the railway vehicles to prevent override. The enclosure system having a coupler centering assembly for maintaining a coupler in a forward position when the enclosure is in the deployed configuration.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Inventors: Robert T. Bocchieri, Alexander D. Zeigle, Steven W. Kirkpatrick, Travis Lowe
  • Publication number: 20230067892
    Abstract: Provided are systems and methods for tactile sensing of a target tissue region of a patient in need thereof.
    Type: Application
    Filed: August 18, 2022
    Publication date: March 2, 2023
    Inventors: Nicole C. MOSKOWITZ, Jessica TRAVER, Xavier GARCIA-ROJAS, Yashar GANJEH, Matthew CRUZ, Jonathan Rae PLUMB, Jack Alexander LOWE, Alexander Keith Gomer Pratten JONES, Geoffrey HUTCHINS, Ann GRAFF, Mahesh VAIDYANATHAN
  • Patent number: 11479546
    Abstract: The application relates to a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted by an arylaminophenyl or heteroarylaminophenyl moiety. The compounds are potent inhibitors of the growth and propagation of the Plasmodium falciparum parasite in human blood and thus useful as pharmaceutical agents for the treatment of malaria.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: October 25, 2022
    Inventors: Teresa De Haro Garcia, Lloyd Malcolm King, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Publication number: 20220289685
    Abstract: A series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives, and analogues thereof, substituted in the 6-position by an arylcarbonylaminophenyl or heteroarylcarbonylaminophenyl moiety, being potent inhibitors of the growth and propagation of the Plasmodium falciparum parasite in human blood, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Application
    Filed: August 17, 2020
    Publication date: September 15, 2022
    Inventors: Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm MacCoss, Richard David Taylor, Zhaoning Zhu, Rose Elizabeth Chappell
  • Publication number: 20220079619
    Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.
    Type: Application
    Filed: April 23, 2021
    Publication date: March 17, 2022
    Inventors: Nicole C. MOSKOWITZ, Jessica TRAVER, Xavier GARCIA-ROJAS, Yashar GANJEH, Matthew CRUZ, Jonathan Rae PLUMB, Jack Alexander LOWE, Alexander Keith Gomer Pratten JONES
  • Publication number: 20220049606
    Abstract: A method for adjusting a surface of an exploratory data model of a geological domain to take into account blast hole data, the method comprising; drilling a plurality of blast holes proximal to the geological domain; recording blast hole data samples for each of the blast holes in an electronic data storage apparatus; operating a processing assembly in data communication with said storage apparatus according to instructions stored in a memory accessible to the processing assembly to perform the following acts: labelling each said data sample as domain or non-domain; determining blast hole boundary samples for the geological domain at each of a number of elevations to produce blast hole boundaries for the geological domain; comparing the blast hole boundaries to a surface of the exploratory data model; adjusting the surface based on the blast hole boundaries for the geological domain to generate an adjusted surface; and mining the geological domain based on the adjusted surface to thereby improve efficiency of
    Type: Application
    Filed: December 18, 2019
    Publication date: February 17, 2022
    Inventors: Danielle Robinson, Mehala Balamurali, Arman Melkumyan, Alexander Lowe, Raymond Leung, Tamara Vasey
  • Patent number: 11136310
    Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: October 5, 2021
    Assignee: UCB Biopharma SRL
    Inventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu
  • Patent number: 11000311
    Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied onto a tissue surface using the tactile sensing device, sensors of a sensor array output voltage signals to a computing device and display screen operatively connected to the sensor array. The sensor array relays its output voltage signals to the computing device, the computing device processes the output voltage signals, and an image of the output voltage signals is visualized on the display screen to help identify a target tissue insertion site.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: May 11, 2021
    Assignee: INTUITAP MEDICAL, INC.
    Inventors: Nicole C. Moskowitz, Jessica Traver, Xavier Garcia-Rojas, Yashar Ganjeh, Matthew Cruz, Jonathan Rae Plumb, Jack Alexander Lowe, Alexander Keith Gomer Pratten Jones
  • Publication number: 20210094941
    Abstract: The application relates to a series of 2-imino-6-methylhexahydropyrimidin-4-one derivatives and 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted by an arylaminophenyl or heteroarylaminophenyl moiety. The compounds are potent inhibitors of the growth and propagation of the Plasmodium falciparum parasite in human blood and thus useful as pharmaceutical agents for the treatment of malaria.
    Type: Application
    Filed: April 2, 2019
    Publication date: April 1, 2021
    Inventors: Teresa De Haro Garcia, Lloyd Malcolm King, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Publication number: 20200399268
    Abstract: The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.
    Type: Application
    Filed: February 15, 2019
    Publication date: December 24, 2020
    Inventors: Jag Paul Heer, Michal Sarah Hallside, Adam Peter Smalley, Josep Llaveria Cros, Benedicte Lallemand, Martin Alexander Lowe, Xianfu Li, Anthony John Richardson, Robert James Townsend
  • Publication number: 20200283416
    Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Application
    Filed: November 24, 2016
    Publication date: September 10, 2020
    Inventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu
  • Patent number: 10654861
    Abstract: A series of substituted fused pentacyclic benzimidazole derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: May 19, 2020
    Assignee: UCB Biopharma SRL
    Inventors: Michael Louis Robert Deligny, Jag Paul Heer, Jean Keyaerts, Luce Elsa Lepissier, Martin Alexander Lowe
  • Patent number: 10464932
    Abstract: A series of 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted in the 5-position by a phenyl moiety NH which in turn is meta-substituted by an optionally substituted fused bicyclic heteroaromatic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: November 5, 2019
    Assignee: UCB Biopharma SPRL
    Inventors: Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Patent number: 10383610
    Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: August 20, 2019
    Assignee: IntuiTap Medical, Inc.
    Inventors: Nicole C. Moskowitz, Jessica Traver, Xavier Garcia-Rojas, Yashar Ganjeh, Matthew Cruz, Jonathan Rae Plumb, Jack Alexander Lowe, Alexander Keith Gomer Pratten Jones
  • Publication number: 20190231332
    Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.
    Type: Application
    Filed: April 9, 2019
    Publication date: August 1, 2019
    Inventors: Nicole C. MOSKOWITZ, Jessica TRAVER, Xavier GARCIA-ROJAS, Yashar GANJEH, Matthew CRUZ, Jonathan Rae PLUMB, Jack Alexander LOWE, Alexander Keith Gomer Pratten JONES
  • Patent number: 10287299
    Abstract: A series of substituted 3,4-dihydro-2H-.1,4-benzoxazin-3-one derivatives, and analogs thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neuradegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: May 14, 2019
    Assignee: UCB Biopharma SPRL
    Inventors: Gareth Neil Brace, Prafulkumar Tulshibhai Chovatia, Gregory Foulkes, James Andrew Johnson, Severine Danielle Jones, Boris Kroeplien, Fabien Claude Lecomte, Pui Leng Loke, Martin Alexander Lowe, Ajay Mandal, Timothy John Norman, Christopher Francis Palmer, Yolanda PĂ©rez-Fuertes, John Robert Porter, Donald Smyth, Giancarlo Trani, Muhammed Uddin, Zhaoning Zhu
  • Publication number: 20190125470
    Abstract: Tactile sensing devices, systems, and methods to image a target tissue location are disclosed. When force is applied to the tactile sensing device, voltage data is detected and visualized on a screen, indicating the target tissue location.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 2, 2019
    Inventors: Nicole C. MOSKOWITZ, Jessica TRAVER, Xavier GARCIA-ROJAS, Yashar GANJEH, Matthew CRUZ, Jonathan Rae PLUMB, Jack Alexander LOWE, Alexander Keith Gomer Pratten JONES
  • Publication number: 20190100525
    Abstract: A series of substituted fused pentacyclic benzimidazole derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 4, 2019
    Inventors: Michael Louis Robert Deligny, Jag Paul Heer, Jean Keyaerts, Luce Elsa Lepissier, Martin Alexander Lowe
  • Publication number: 20190040053
    Abstract: A series of 3-imino-5-methyl-1,2,4-thiadiazinane 1,1-dioxide derivatives of formula (I), substituted in the 5-position by a phenyl moiety NH which in turn is meta-substituted by an optionally substituted fused bicyclic heteroaromatic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Application
    Filed: February 22, 2017
    Publication date: February 7, 2019
    Inventors: Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Richard David Taylor, Zhaoning Zhu
  • Patent number: 9988383
    Abstract: A series of substituted purine derivatives, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: June 5, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Victoria Elizabeth Jackson, Boris Kroeplien, Martin Alexander Lowe, John Robert Porter